Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-Protocol ALL-99 (2010)
- Authors:
- Brandalise, Silvia R.
- Pinheiro, Vitória R.
- Aguiar, Simone S.
- Matsuda, Eduardo I.
- Otubo, Rosemary
- Yunes, José A.
- Pereira, Waldir A.
- Carvalho, Eny G.
- Cristofani, Lilian M.
- Souza, Marcelo S.
- Lee, Maria L.
- Dobbin, Jane A.
- Pombo-de-Oliveira, Maria S.
- Lopes, Luiz F.
- Melnikoff, Katharina N. T.
- Brunetto, Algemir L.
- Tone, Luiz Gonzaga
- Scrideli, Carlos Alberto
- Morais, Vera L. L.
- Viana, Marcos B.
- USP affiliated authors: TONE, LUIZ GONZAGA - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP
- Unidade: FMRP
- Subjects: CRIANÇAS; LEUCEMIA (TRATAMENTO)
- Language: Inglês
- Imprenta:
- Publisher place: Alexandria
- Date published: 2010
- Source:
- Título do periódico: Journal of Clinical Oncology
- ISSN: 0732-183X
- Volume/Número/Paginação/Ano: v. 28, n. 11, p. 1911-1918, 2010
-
ABNT
BRANDALISE, Silvia R. et al. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-Protocol ALL-99. Journal of Clinical Oncology, v. 28, n. 11, p. 1911-1918, 2010Tradução . . Acesso em: 15 maio 2024. -
APA
Brandalise, S. R., Pinheiro, V. R., Aguiar, S. S., Matsuda, E. I., Otubo, R., Yunes, J. A., et al. (2010). Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-Protocol ALL-99. Journal of Clinical Oncology, 28( 11), 1911-1918. -
NLM
Brandalise SR, Pinheiro VR, Aguiar SS, Matsuda EI, Otubo R, Yunes JA, Pereira WA, Carvalho EG, Cristofani LM, Souza MS, Lee ML, Dobbin JA, Pombo-de-Oliveira MS, Lopes LF, Melnikoff KNT, Brunetto AL, Tone LG, Scrideli CA, Morais VLL, Viana MB. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-Protocol ALL-99. Journal of Clinical Oncology. 2010 ; 28( 11): 1911-1918.[citado 2024 maio 15 ] -
Vancouver
Brandalise SR, Pinheiro VR, Aguiar SS, Matsuda EI, Otubo R, Yunes JA, Pereira WA, Carvalho EG, Cristofani LM, Souza MS, Lee ML, Dobbin JA, Pombo-de-Oliveira MS, Lopes LF, Melnikoff KNT, Brunetto AL, Tone LG, Scrideli CA, Morais VLL, Viana MB. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-Protocol ALL-99. Journal of Clinical Oncology. 2010 ; 28( 11): 1911-1918.[citado 2024 maio 15 ] - Inibição do crescimento e redução da capacidade clonogênica em linhagens celulares de glioblastomas pediátricos e adultos através do DHMEQ
- Acute lymphoblastic leukemia analyzed by comparative genome hybridization(CGH)
- mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia, low expression levels associated with a higher risk of toxic death
- microRNA expression in childhood acute lymphoblastic leukemia: identification of microRNAs involved in leukemogenesis and prognosis
- Decreased expression of BATF2 is significantly associatedwith poor prognosis in childhood medulloblastoma
- Analysis of molecular pathways by Rnaseq following GDF15 knockdown in paediatric and adult glioblastoma cell lines
- Tetraploidization in Wilms tumor in an infant
- Bloom's and myelodysplastic syndromes: report of a rare pediatric case with gain of an isochromosome 5p. [Carta]
- Alternative targets for medulloblastoma treatment: polo-like kinase 1
- Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
